Allogenicity Boosts Extracellular Vesicle-Induced Antigen-Specific Immunity and Mediates Tumor Protection and Long-Term Memory In Vivo.

Allogenicity Boosts Extracellular Vesicle-Induced Antigen-Specific Immunity and Mediates Tumor Protection and Long-Term Memory In Vivo.

Publication date: Jul 10, 2019

Extracellular vesicles (EV) are candidates for cancer immunotherapy because of their capacity to stimulate tumor-specific activity in vivo. However, clinical trials using peptide-loaded autologous EVs have so far only showed moderate T cell responses, suggesting a need for optimization of EV-induced immunity in humans. We previously demonstrated that induction of Ag-specific CD8 T cells and antitumor responses to whole Ag were independent of MHC class I on EVs and hypothesized that multiple injections of allogeneic EVs could potentiate Ag-specific responses. In this study, we show that the allogeneic EV from mouse bone marrow-derived dendritic cells enhances Ag-specific CD8 T cell, follicular helper T cell, and Ag-specific Ab responses. EV-injected mice demonstrated Ag-specific memory after 4 mo, with the highest Ab avidity in mice receiving double allogeneic EV injections. Reduced B16mOVA melanoma tumor growth was shown in all EV-injected groups. Our findings support the application of allogeneic EVs for therapeutic use in clinical studies in which an adaptive immune response is desired.

Larssen, P., Veerman, R.E., Akpinar, G.G., Hiltbrunner, S., Karlsson, M.C.I., and Gabrielsson, S. Allogenicity Boosts Extracellular Vesicle-Induced Antigen-Specific Immunity and Mediates Tumor Protection and Long-Term Memory In Vivo. 23353. 2019 J Immunol.

Concepts Keywords
Allogeneic B16mOVA melanoma tumor
Antigen Immunotherapy
Autologous Branches of biology
Bone Marrow Vesicles
CD8 Cell biology
Clinical Trials Cells
Follicular Extracellular vesicle
Immunity Cancer treatments
Immunotherapy Immunotherapy
Melanoma Exosome
Memory
MHC
Optimization
Peptide
Tumor
Vesicles
Vivo

Semantics

Type Source Name
disease MESH growth
pathway BSID Melanoma
disease DOID melanoma
disease MESH melanoma
disease MESH multiple
gene UNIPROT HLA-C
gene UNIPROT CD8A
disease DOID cancer
disease MESH Tumor

Similar

Original Article

Leave a Comment

Your email address will not be published. Required fields are marked *